相关实验视频

Updated: Jun 26, 2025

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

在西班牙获得黑色素瘤药物:一个横截面调查

Maria Gonzalez-Cao¹, Teresa Puertolas², Jose Luis Manzano³

¹Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, C/Sabino Arana, 5, 080028, Barcelona, Spain. mgonzalezcao@oncorosell.com.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

|May 15, 2024

概括

在西班牙,黑色素瘤患者获得药物的机会因地区而异,特别是无偿治疗. 这种分散的系统在获得先进的黑色素瘤疗法方面造成了不平等.

科学领域:

在瘤学瘤学.
医疗保健服务研究医疗服务研究
药物经济学药物经济学

背景情况:

高成本的黑色素瘤药物提高了生存率,但却给医疗保健系统带来了压力.
西班牙由17个自治区 (AACC) 管理的分散医疗保健影响了药物获取.
了解黑色素瘤药物获取的区域差异对于公平的患者护理至关重要.

研究的目的:

评估西班牙自治区内黑色素瘤患者目前的药物获取情况.
分析分散的医疗保健系统如何影响黑色素瘤治疗的公平性.

主要方法:

从2023年7月到9月,向西班牙多学科黑色素瘤小组 (GEM小组) 分发了一项横截面调查.
医生报告说,他们的医院在现实世界中可以获得新的黑色素瘤药物.
数据是匿名收集和分析的,考虑到自治社区 (AACC) 之间的差异.

主要成果:

15个AACC的50名医生参与了调查.
报销的治疗显示了AACC之间的最低限度的访问差异.
在非补偿或部分补偿的治疗中,在AACC之间和内部都发现了显著的获取差异.
获得辅助向药物,TIL治疗和T-VEC的机会均低或不存在.

结论:

西班牙的去中心化导致人们在标准退款之外的病症中获得不同类型的黑色素瘤药物.
在自治社区内和跨自治社区之间,药物获取存在显著的异质性.
目前的系统对公平获得新型黑色素瘤疗法提出了挑战.

关键词:

访问访问访问访问访问创新的治疗方法黑色素瘤是一种黑色素瘤.

更多相关视频

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

相关概念视频

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...